Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Tuberculosis screening yield of asylum seekers in Europe

Gerard de Vries, Job van Rest, Wieneke Meijer, Henrieke Schimmel, Bert Wolters, Rob van Hest, Michael Kimerling
European Respiratory Journal 2016 48: 1255-1256; DOI: 10.1183/13993003.01617-2016
Gerard de Vries
1KNCV Tuberculosis Foundation, Den Haag, The Netherlands
2Centre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gerard.devries@kncvtbc.org
Job van Rest
1KNCV Tuberculosis Foundation, Den Haag, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wieneke Meijer
3Dept of TB Control, Municipal Public Health Services Amsterdam, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henrieke Schimmel
2Centre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bert Wolters
4Dept of TB Control, Regional Public Health Services Groningen, Groningen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rob van Hest
4Dept of TB Control, Regional Public Health Services Groningen, Groningen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Kimerling
1KNCV Tuberculosis Foundation, Den Haag, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

There is need to collect, analyse and compare TB screening data from migrants in EU countries more systematically http://ow.ly/x2eQ303k2CK

From the authors:

We thank W. Arranzola de Oñate and colleagues for their correspondence on our article “Low yield of screening asylum seekers from countries with a tuberculosis incidence of <50 per 100 000 population” [1]. They report a 4–5 times higher tuberculosis (TB) prevalence among Syrian asylum seekers at entry screening in Belgium (94.2 or 107.6 per 100 000 screened persons, depending on definition used) than we found in the Netherlands. We would like to elaborate on possible explanations for the differences in screening yield, some of which were also mentioned by Arranzola de Oñate and colleagues.

The Dutch data include almost all Syrian asylum seekers, since screening was mandatory in the Netherlands in the study period and done within the first few days after asylum application. In contrast to Belgium, children <5 years of age and pregnant women are also screened in the Netherlands. Children <5 years of age accounted for 9.7% of the Syrian asylum seeker population in our study and none of them had TB at entry screening. Information on the number of pregnant women was not available, but the number is assumed to be small. It is unlikely that these differences in individuals targeted for screening explain the different TB prevalence rates in the two countries.

If we compare radiographic screening results of Syrian asylum seekers in Belgium (TB prevalence 94.2 per 100 000 screened persons; 95% CI 41.2–186.3) and the Netherlands (prevalence 22.2 per 100 000 screened persons; 95% CI 9.7–44.0) then these differences are significant (p=0.01). The Belgium study is based on a smaller number of screened persons (7432 versus 31 470 in our study) and included screening data from 2015 only, while our study covered almost 5 years (January 2011-September 2015). We agree that TB prevalence may gradually change over time in populations affected by war and disaster. Table 1 shows that in the Netherlands most Syrian refugees (94%) were screened in 2014 and 2015 and all Syrian TB cases were identified in these 2 years. It would be interesting to know the Belgian screening results for Syrian refugees in 2014 to see if TB prevalence has changed over time.

View this table:
  • View inline
  • View popup
TABLE 1

Results of screening Syrian asylum seekers in the Netherlands, 2011–mid-September 2015

In the Netherlands, maximum efforts are made to confirm the TB diagnosis. In our study, 10 (83%) out of 12 asylum seekers with TB were confirmed by a positive culture for Mycobacterium tuberculosis. A recent overview of screening in the main reception centre in the Netherlands reported culture confirmation in 48 (87%) out of 55 identified cases at entry screening [2]. It would be interesting to learn how many of the (Syrian) asylum seekers detected upon entry screening in Belgium had culture-confirmed TB. Empirical treatment of abnormalities possibly compatible with pulmonary TB could explain a higher prevalence of screening in Belgium.

We cannot substantiate whether Syrian asylum seekers arriving in Belgium are a different subgroup using different refugee routes, but this assumption seems unlikely to explain the difference in prevalence of screening. A more obvious explanation could be when clustered cases occur and are included in the study, e.g. a family with several TB cases. In the Netherlands, all M. tuberculosis isolates are subject to DNA fingerprinting and none of the culture-confirmed Syrian TB cases had identical variable number of tandem repeat genotypes or were epidemiologically linked.

We closely monitor the TB situation among asylum seekers, in particular among Syrians after screening was discontinued. We estimated that ∼2000 of the 5259 Syrians applying for asylum in September 2015 were not screened (screening was stopped on September 21, 2015, but was already incomplete before this date when refugees were housed in emergency shelters). In the fourth quarter of 2015 and in the first and second quarters of 2016, respectively, 11 060, 2230 and 1058 Syrians requested asylum in the Netherlands [3], giving a total of 16 348 unscreened Syrian asylum seekers (from mid-September 2015 up until June 30, 2016). Since mid-September 2015, 12 Syrian TB patients were reported to the Netherlands Tuberculosis Register (up until June 30, 2016). Two patients were included in the previous analysis since they had an abnormal chest radiograph at entry screening (one arrived in August 2015 and one in September 2015) and were confirmed by a positive M. tuberculosis culture in the fourth quarter of 2015. Six patients arrived in the Netherlands before discontinuation of screening and were diagnosed between 6–14 months after arrival. Four patients arrived in the Netherlands after discontinuation of screening: three of them were diagnosed with pulmonary TB 0–5 months after arrival, and one with pulmonary TB more than 6 months after arrival. If we assume that the three pulmonary TB patients identified after less than 6 months in the Netherlands potentially could have been identified by radiographic screening this would have resulted in a TB prevalence of 18.4 per 100 000 screened persons (95% CI 4.8–50.0), which is similar to the TB prevalence in our study.

In conclusion, we would like to state that our analysis of entry screening was robust and that close monitoring of the TB situation among Syrian asylum seekers after discontinuation of screening also indicates that their risk for TB is relatively low. The Belgian and Dutch studies on screening (Syrian) asylum seekers show the importance of collecting migrant screening data in a more uniform and systematic way, and reporting on countries' TB screening data and experiences, to better understand screening effectiveness and differences in results between countries. In the recently awarded project, E-Detect TB, by the European Commission several European Union countries are collaborating to pool their screening data together and analyse it [4]. European Union countries not participating in the project will also be invited to join this initiative in a later stage.

Footnotes

  • Conflict of interest: None declared.

  • Received August 12, 2016.
  • Accepted August 15, 2016.
  • Copyright ©ERS 2016

References

  1. ↵
    1. de Vries G,
    2. van Rest J,
    3. Meijer W, et al.
    Low yield of screening asylum seekers from countries with a tuberculosis incidence of <50 per 100 000 population. Eur Respir J 2016; 47: 1870–1872.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Akkerman OW,
    2. de Lange WCM,
    3. Schölvinck EH, et al.
    Implementing tuberculosis entry screening for asylum seekers: the Groningen experience. Eur Respir J 2016; 48: 261–264.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Ministry of Security and Justice. Immigration and Naturalisation Service (IND). Asylum Trends: Monthly Report on Asylum Applications in The Netherlands and Europe. June 2016. Rijswijk, Ministry of Security and Justice, Immigration and Naturalisation Service (IND), 2016. https://ind.nl/Documents/Asylum%20Trends%20June%202016.pdf
  4. ↵
    E-DETECT TB. https://e-detecttb.eu/ Date last accessed: August 21, 2016. Date last updated: August 21, 2016.
PreviousNext
Back to top
View this article with LENS
Vol 48 Issue 4 Table of Contents
European Respiratory Journal: 48 (4)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Tuberculosis screening yield of asylum seekers in Europe
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Tuberculosis screening yield of asylum seekers in Europe
Gerard de Vries, Job van Rest, Wieneke Meijer, Henrieke Schimmel, Bert Wolters, Rob van Hest, Michael Kimerling
European Respiratory Journal Oct 2016, 48 (4) 1255-1256; DOI: 10.1183/13993003.01617-2016

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Tuberculosis screening yield of asylum seekers in Europe
Gerard de Vries, Job van Rest, Wieneke Meijer, Henrieke Schimmel, Bert Wolters, Rob van Hest, Michael Kimerling
European Respiratory Journal Oct 2016, 48 (4) 1255-1256; DOI: 10.1183/13993003.01617-2016
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Airway immune responses to COVID-19 vaccination in COPD patients
  • Wider access to rifapentine-based regimens is needed for TB care globally
  • Screening for PVOD in heterozygous EIF2AK4 variant carriers
Show more Agora

Correspondence

  • Risk factors for disease progression in fibrotic hypersensitivity pneumonitis
  • Optimised surveillance of bronchial dysplasia in risky population
  • Reply: Risk factors for disease progression in fibrotic hypersensitivity pneumonitis
Show more Correspondence

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society